PHIO - Phio Pharmaceuticals Corp
1.16
-0.010 -0.862%
Share volume: 328,399
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$1.17
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-14-2024 | 11-14-2024 | 05-15-2025 | 08-14-2025 | 11-13-2025 | 03-05-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | |||
| Operating expenses | 2.209 M | 1.914 M | 1.590 M | 1.872 M | 2.309 M | 2.505 M | 2.534 M | |
| Selling general and admin | 1.061 M | 1.048 M | 946.000 K | 986.000 K | 1.235 M | 1.324 M | 1.057 M | |
| Research and development | 1.148 M | 866.000 K | 644.000 K | 886.000 K | 1.074 M | 1.181 M | 1.477 M | |
| Total expenses | 2.209 M | 1.914 M | 1.590 M | 1.872 M | 2.309 M | 2.505 M | 2.534 M | |
| -13.35% | -16.93% | 17.74% | 23.34% | 8.49% | 1.16% | |||
| Operating income | -2.209 M | -1.914 M | -1.590 M | -1.872 M | -2.309 M | -2.505 M | -2.534 M | |
| Ebit | -2.154 M | -1.846 M | -1.524 M | -1.872 M | -2.166 M | -2.505 M | -2.534 M | |
| Pretax income | -2.154 M | -1.846 M | -1.524 M | -1.747 M | -2.166 M | -2.392 M | -2.393 M | |
| -14.30% | -17.44% | 14.63% | 23.98% | 10.43% | 0.04% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.154 M | -1.846 M | -1.524 M | -1.769 M | -2.166 M | -2.392 M | -2.371 M | |
| 14.30% | 17.44% | -16.08% | -22.44% | -10.43% | 0.88% |